No Picture
News

Mirati Therapeutics Announces Closing Of Public Offering Of Common Stock And Full Exercise Of Underwriters’ Option To Purchase Additional Shares

SAN DIEGO, June 27, 2019 /PRNewswire/ — Mirati Therapeutics, Inc. (Nasdaq: MRTX) today announced the closing of its previously announced underwritten public offering of 2,415,000 shares of its common stock at a public offering price of $97.00 per s… […]

No Picture
News

Cibus Postpones Initial Public Offering

SAN DIEGO, Feb. 14, 2019 /PRNewswire/ — Cibus, a leader in advanced plant-breeding technologies, today announced it has postponed plans for an initial public offering.
“We elected to postpone our offering given current market and technical conditi… […]

No Picture
News

Mirati Therapeutics Announces Closing Of Public Offering Of Common Stock And Full Exercise Of Underwriters’ Option To Purchase Additional Shares

SAN DIEGO, Jan. 22, 2019 /PRNewswire/ — Mirati Therapeutics, Inc. (Nasdaq: MRTX) today announced the closing of its previously announced underwritten public offering of 1,854,838 shares of its common stock at a public offering price of $62.00 per s… […]